1. Home
  2. Products
  3. Customized FluoroAb™
  4. CD79b
  5. Anti-CD79B MAb (Clone 8)-iFluor® 430 Succinimidyl Ester

Anti-CD79B MAb (Clone 8)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3421)

This product is comprised of an Anti-CD79B IgG1 Antibody (Clone 8) labeled with iFluor® 430 Succinimidyl Ester. iFluor® 430 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.

  • TARGET
  • ANTIBODY
  • DYE
  • Name
  • CD79B
  • Alternative Names
  • CD79B; AGM6; B29; IGB; CD79b molecule; Igbeta
  • Overview
  • Anti-CD79B IgG1 Antibody (Clone 8)
  • Species Reactivity
  • Human
  • Name
  • iFluor® 430 Succinimidyl Ester
  • Color
  • Green
  • Excitation⁄Emission (nm)
  • 433/498
  • Detection method
  • Fluorescent

For Research Use Only. NOT FOR CLINICAL USE.

Published Data

+ Submit Publications

Submit a review or a question

Scientific Resources

Customer Reviews and FAQs

There are currently no Customer reviews or questions for WJY0-LS3421. Click the button above to contact us or submit your feedback about this product.

Quick Links

Other Products

Same Target
CAT# Product Name Linker Payload
ADC-W-380 Anti-CD79B (Polatuzumab)-Mc-VC-PABC-MMAE ADC MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) MMAE (Monomethyl auristatin E)
ADC-W-222 Anti-CD79b (SN8)-SPP-DM1 ADC SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate) DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine)
ADC-W-225 Anti-CD79b (SN8)-Mc-MMAF ADC Mc (maleimidocaproyl) MMAF (Monomethyl auristatin F)
ADC-W-223 Anti-CD79b (SN8)-MCC-DM1 ADC MCC (Maleimidomethyl cyclohexane-1-carboxylate) DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine)
ADC-W-2557 Anti-CD79B (Polatuzumab )-MC-Vc-PAB-MMAE ADC MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) MMAE

Online Inquiry

Name:
*Phone:
*E-mail Address:
*Products or Services Interested:
Company/Institution
Project Description:

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.